| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Gastrointestinal Imaging |
1 From the Department of Diagnostic Radiology and the Research Institute of Radiological Science, Yonsei University College of Medicine, YongDong Severance Hospital, 146-92 Dokok-Dong, Kangnam-Ku, Seoul 135-270, South Korea. Received July 14, 1999; revision requested August 25; revision received February 11, 2000; accepted March 30. Address correspondence to J.S.Y. (e-mail: yjsrad97@yumc.yonsei.ac.kr).
PURPOSE: To determine the magnetic resonance (MR) imaging findings of small nontumorous hepatic arterial–portal venous (arterioportal) shunts in the liver.
MATERIALS AND METHODS: MR images in 25 patients with 38 small nontumorous arterioportal shunts verified with surgery or follow-up imaging were included in this study. The causes of arterioportal shunts were iatrogenic causes in 11 patients and/or cirrhotic changes in the remaining patients. Nonenhanced T1- and T2-weighted images and multiphase contrast material–enhanced dynamic images were retrospectively reviewed and compared with conventional hepatic arteriograms to determine the MR characteristics related to the focal hemodynamic changes.
RESULTS: On arterial-dominant–phase dynamic MR images, 29 (76%) of the 38 arteriographically suggested nontumorous arterioportal shunts displayed abnormal findings distinguished against the surrounding hepatic parenchyma, including wedge-shaped (n = 14), nodular (n = 9), or irregularly outlined (n = 6) areas of focal contrast enhancement. The signal intensity on nonenhanced T1- and T2-weighted images of the corresponding areas appeared unremarkable except for three wedge-shaped high-signal-intensity areas (three [8%] of 38) on T2-weighted images accompanied by prolonged contrast enhancement. Most (24 [83%] of 29) areas of abnormal signal intensity were located at the periphery of the liver parenchyma.
CONCLUSION: A small nontumorous arterioportal shunt should be considered one of the causes of focal parenchymal hyperperfusion abnormalities on contrast-enhanced dynamic MR images of the liver in the absence of abnormal signal intensity on static MR images.
Index terms: Liver, angiography, 761.1242 • Liver, cirrhosis, 761.794 • Liver, MR, 761.121412, 761.12143 • Shunts, arterioportal, 952.453, 957.453
This article has been cited by other articles:
|
|
 |
|
  Y K KIM, C S KIM, and Y M HAN Detection of small hepatocellular carcinoma: comparison of conventional gadolinium-enhanced MRI with gadolinium-enhanced MRI after the administration of ferucarbotran Br. J. Radiol., June 1, 2009; 82(978): 468 - 484. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. H. Choi, J. M. Lee, N. C. Yu, K.-S. Suh, J.-J. Jang, S. H. Kim, and B. I. Choi Hepatocellular Carcinoma in Liver Transplantation Candidates: Detection with Gadobenate Dimeglumine-Enhanced MRI Am. J. Roentgenol., August 1, 2008; 191(2): 529 - 536. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Willatt, H. K. Hussain, S. Adusumilli, and J. A. Marrero MR Imaging of Hepatocellular Carcinoma in the Cirrhotic Liver: Challenges and Controversies Radiology, May 1, 2008; 247(2): 311 - 330. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Choi, D. G. Mitchell, S. K. Verma, D. Bergin, V. J. Navarro, A. B. Malliah, C. McGowan, H.-W. L. Hann, and S. K. Herrine Hepatocellular Carcinoma with Indeterminate or False-Negative Findings at Initial MR Imaging: Effect on Eligibility for Curative Treatment Initial Observations Radiology, September 1, 2007; 244(3): 776 - 783. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Catalano, F. Sandomenico, A. Nunziata, M. M. Raso, P. Vallone, and A. Siani Transient Hepatic Echogenicity Difference on Contrast-Enhanced Ultrasonography: Sonographic Sign and Pitfall J. Ultrasound Med., March 1, 2007; 26(3): 337 - 345. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-S. Yu, J.-G. Park, E.-K. Jeong, M.-S. Park, and K. W. Kim Hepatic MRI Using the Double-Echo Chemical Shift Phase-Selective Gradient-Echo Technique Am. J. Roentgenol., January 1, 2007; 188(1): W49 - W56. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Hecht, A. E. Holland, G. M. Israel, W. Y. Hahn, D. C. Kim, A. B. West, J. S. Babb, B. Taouli, V. S. Lee, and G. A. Krinsky Hepatocellular Carcinoma in the Cirrhotic Liver: Gadolinium-enhanced 3D T1-weighted MR Imaging as a Stand-alone Sequence for Diagnosis. Radiology, May 1, 2006; 239(2): 438 - 447. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. E. Holland, E. M. Hecht, W. Y. Hahn, D. C. Kim, J. S. Babb, V. S. Lee, A. B. West, and G. A. Krinsky Importance of Small (<=20-mm) Enhancing Lesions Seen Only during the Hepatic Arterial Phase at MR Imaging of the Cirrhotic Liver: Evaluation and Comparison with Whole Explanted Liver Radiology, December 1, 2005; 237(3): 938 - 944. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Y. Jeong, N. Y. Yim, and H. K. Kang Hepatocellular Carcinoma in the Cirrhotic Liver with Helical CT and MRI: Imaging Spectrum and Pitfalls of Cirrhosis-Related Nodules Am. J. Roentgenol., October 1, 2005; 185(4): 1024 - 1032. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. V. Pandharipande, G. A. Krinsky, H. Rusinek, and V. S. Lee Perfusion Imaging of the Liver: Current Challenges and Future Goals Radiology, March 1, 2005; 234(3): 661 - 673. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kanematsu, S. Goshima, H. K. Hussain, T. D. Johnson, H. V. Nghiem, and I. R. Francis Does T2-weighted MR Imaging Really Add No Value in Detection and Characterization of Focal Lesions in Cirrhotic Liver? * Dr Hussain and colleagues respond: Radiology, February 1, 2005; 234(2): 638 - 640. [Full Text]
|
|
|
|
|
|
K. Ito, T. Fujita, A. Shimizu, S. Koike, K. Sasaki, N. Matsunaga, S. Hibino, and M. Yuhara Multiarterial Phase Dynamic MRI of Small Early Enhancing Hepatic Lesions in Cirrhosis or Chronic Hepatitis: Differentiating Between Hypervascular Hepatocellular Carcinomas and Pseudolesions Am. J. Roentgenol., September 1, 2004; 183(3): 699 - 705. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. K. Hussain, I. Syed, H. V. Nghiem, T. D. Johnson, R. C. Carlos, W. J. Weadock, and I. R. Francis T2-weighted MR Imaging in the Assessment of Cirrhotic Liver Radiology, March 1, 2004; 230(3): 637 - 644. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Shimizu, K. Ito, S. Koike, T. Fujita, K. Shimizu, and N. Matsunaga Cirrhosis or Chronic Hepatitis: Evaluation of Small (<=2-cm) Early-Enhancing Hepatic Lesions with Serial Contrast-enhanced Dynamic MR Imaging Radiology, February 1, 2003; 226(2): 550 - 555. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. Heiken Invited Commentary RadioGraphics, September 1, 2002; 22(5): 1037 - 1039. [Full Text] [PDF]
|
|
|
|
|
|
Y. Y. Jeong, D. G. Mitchell, and T. Kamishima Small (<20 mm) Enhancing Hepatic Nodules Seen on Arterial Phase MR Imaging of the Cirrhotic Liver: Clinical Implications Am. J. Roentgenol., June 1, 2002; 178(6): 1327 - 1334. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Gallego, M. Velasco, P. Marcuello, D. Tejedor, L. De Campo, and A. Friera Congenital and Acquired Anomalies of the Portal Venous System RadioGraphics, January 1, 2002; 22(1): 141 - 159. [Abstract] [Full Text] [PDF]
|
|
